There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Palatin Technologies (PTN – Research Report), ANI Pharmaceuticals (ANIP – Research Report) and Theravance Biopharma (TBPH – Research Report) with bullish sentiments.
Palatin Technologies (PTN)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Palatin Technologies, with a price target of $70.00. The company’s shares closed last Monday at $2.26, close to its 52-week low of $2.08.
According to TipRanks.com, Pantginis is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Palatin Technologies with a $60.00 average price target, implying a 2730.2% upside from current levels. In a report issued on May 1, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $50.00 price target.
See the top stocks recommended by analysts >>
ANI Pharmaceuticals (ANIP)
In a report released today, Oren Livnat from H.C. Wainwright maintained a Buy rating on ANI Pharmaceuticals, with a price target of $60.00. The company’s shares closed last Monday at $42.58.
According to TipRanks.com, Livnat is a 2-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for ANI Pharmaceuticals with a $52.33 average price target, implying a 8.0% upside from current levels. In a report issued on May 1, Raymond James also maintained a Buy rating on the stock.
Theravance Biopharma (TBPH)
H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Theravance Biopharma today and set a price target of $20.00. The company’s shares closed last Monday at $11.33, close to its 52-week high of $12.03.
According to TipRanks.com, Tsao is a 5-star analyst with an average return of
Theravance Biopharma has an analyst consensus of Moderate Buy, with a price target consensus of $14.33.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PTN:
